BRANCATO, VIRGINIA
 Distribuzione geografica
Continente #
AS - Asia 2.478
NA - Nord America 2.199
EU - Europa 1.705
SA - Sud America 379
Continente sconosciuto - Info sul continente non disponibili 145
AF - Africa 61
OC - Oceania 13
Totale 6.980
Nazione #
US - Stati Uniti d'America 2.093
SG - Singapore 820
IT - Italia 794
CN - Cina 571
HK - Hong Kong 318
BR - Brasile 278
VN - Vietnam 277
RU - Federazione Russa 224
FR - Francia 156
IE - Irlanda 107
KR - Corea 84
DE - Germania 83
GB - Regno Unito 74
IN - India 74
BD - Bangladesh 72
FI - Finlandia 57
CA - Canada 52
ID - Indonesia 44
NL - Olanda 40
AR - Argentina 39
TR - Turchia 38
JP - Giappone 34
SE - Svezia 31
ZA - Sudafrica 30
MX - Messico 28
PL - Polonia 24
CO - Colombia 23
IQ - Iraq 23
CH - Svizzera 17
PH - Filippine 17
ES - Italia 16
PT - Portogallo 16
PK - Pakistan 15
SA - Arabia Saudita 15
AT - Austria 14
CZ - Repubblica Ceca 13
CL - Cile 12
UZ - Uzbekistan 12
TW - Taiwan 11
AU - Australia 9
JO - Giordania 9
EC - Ecuador 8
MA - Marocco 8
MY - Malesia 7
UA - Ucraina 7
IR - Iran 6
KE - Kenya 6
PY - Paraguay 6
JM - Giamaica 5
NP - Nepal 5
BO - Bolivia 4
CR - Costa Rica 4
DZ - Algeria 4
EG - Egitto 4
GR - Grecia 4
HN - Honduras 4
LT - Lituania 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
RO - Romania 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BE - Belgio 3
DK - Danimarca 3
HR - Croazia 3
LB - Libano 3
OM - Oman 3
PE - Perù 3
AZ - Azerbaigian 2
BB - Barbados 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
ET - Etiopia 2
GD - Grenada 2
GT - Guatemala 2
IL - Israele 2
KZ - Kazakistan 2
NI - Nicaragua 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
UY - Uruguay 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
DM - Dominica 1
GE - Georgia 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
NO - Norvegia 1
QA - Qatar 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 6.835
Città #
Singapore 473
San Jose 363
Milan 302
Hong Kong 292
Ashburn 264
Hefei 150
Council Bluffs 109
Dublin 102
Ho Chi Minh City 102
Beijing 91
New York 82
Seoul 78
Dallas 77
Chicago 73
Los Angeles 73
Santa Clara 71
Hanoi 61
The Dalles 57
Rome 52
Buffalo 47
Helsinki 41
Lauterbourg 41
Columbus 37
Jakarta 33
São Paulo 32
Atlanta 23
Moscow 23
Tokyo 21
Turin 21
Johannesburg 20
Phoenix 20
Shanghai 19
Frankfurt am Main 18
Houston 17
Montreal 17
Warsaw 17
Chennai 15
Groningen 15
Guangzhou 15
London 15
Naples 15
Boardman 14
Bologna 14
Nuremberg 14
Baghdad 13
Brescia 13
Brooklyn 13
Da Nang 13
Orem 13
Tukwila 13
Denver 12
Florence 12
Munich 12
Braga 11
Hyderabad 11
Monza 11
Salt Lake City 10
Washington 10
Zurich 10
Amman 9
Amsterdam 9
Dhaka 9
Figino 9
Istanbul 9
Tashkent 9
Ankara 8
Rio de Janeiro 8
Toronto 8
Boston 7
Buenos Aires 7
Riyadh 7
Birmingham 6
Biên Hòa 6
Brno 6
Busto Arsizio 6
Bắc Ninh 6
Cagliari 6
Chengdu 6
Falkenstein 6
Ha Long 6
Lahore 6
Manchester 6
Mexico City 6
Miami 6
Poplar 6
Seattle 6
Vienna 6
Berlin 5
Brasília 5
Charlotte 5
City of London 5
Curitiba 5
Detroit 5
Duque de Caxias 5
Gwanak-gu 5
Haiphong 5
Lewistown 5
Milwaukee 5
Mumbai 5
Nairobi 5
Totale 3.873
Nome #
Chitosan-Based Biomaterials: Insights into Chemistry, Properties, Devices, and Their Biomedical Applications 413
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 308
Hexosamine Pathway inhibition: one molecule able to induce a Brcaness phenotype as promising cancer therapy 278
Mechanical Property of Hydrogels and the Presence of Adipose Stem Cells in Tumor Stroma Affect Spheroid Formation in the 3D Osteosarcoma Model 277
PGM3 inhibition Shows cooperative Effects With Erastin inducing Pancreatic cancer cell death via activation of the Unfolded Protein Response 277
3D Bioprinting for Cancer Models 240
PGM3 inhibition shows cooperative effects with Erastin inducing pancreatic cancer cell death via activation of the Unfolded Protein Response 238
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 225
PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells 220
Hexosamine Biosynthetic Pathway inhibition sensitizes pancreatic cancer cells to DNA damage 194
Targeting the Unfolded Protein Response for Breast and Pancreatic Cancer Therapy 187
Tumor-Associated Protrusion Fluctuations as a Signature of Cancer Invasiveness 181
Targeting the Hexosamine Biosynthetic Pathway with a novel PGM3 inhibitor, FR054, to suppress tumour growth and enhance chemotherapy sensitivity in cancer 178
PGM3 Inhibition as a Novel Strategy to Induce BRCAness in HR-Proficient Pancreatic Cancer Cells 169
Synergistic Effect of Co-Culturing Breast Cancer Cells and Fibroblasts in the Formation of Tumoroid Clusters and Design of In Vitro 3D Models for the Testing of Anticancer Agents 166
Convection patterns gradients of non-living and living micro-entities in hydrogels 163
Silk fibroin promotes mineralization of gellan gum hydrogels 162
Could 3D models of cancer enhance drug screening? 161
Fibroblasts Impair Migration and Antitumor Activity of NK-92 Lymphocytes in a Melanoma-on-Chip Model 158
Hexosamine Biosynthetic Pathway inhibition cooperates with gemcitabine inducing in vitro and in vivo pancreatic cancer regression by enhancing DNA damage 145
News from around the RNA world: new avenues in RNA biology, biotechnology and therapeutics from the 2022 SIBBM meeting 144
3D cancer spheroids and microtissues 144
Tumor-stroma interactions alter the sensitivity of drug in breast cancer 136
adipoSIGHT in Therapeutic Response: Consequences in Osteosarcoma Treatment 134
Coupling Micro-Physiological Systems and Biosensors for Improving Cancer Biomarkers Detection 130
Bioengineered tumoral microtissues recapitulate desmoplastic reaction of pancreatic cancer 129
Design of inhibitors of influenza virus membrane fusion: Synthesis, structure-activity relationship and in vitro antiviral activity of a novel indole series 125
An Engineered Breast Cancer Model on a Chip to Replicate ECM-Activation In Vitro during Tumor Progression 125
3D is not enough: Building up a cell instructive microenvironment for tumoral stroma microtissues 118
Bioengineered Tumoral Microtissue: An In Vitro 3D Platform To Investigate Cell-ECM Interaction And Cancer Development 116
3D tumor microtissues as an in vitro testing platform for microenvironmentally-triggered drug delivery systems 114
Targeting Hexosamine Biosynthetic Pathway to Overcome Resistance in Pancreatic Cancer Treatment 114
Exploiting DNA damage protein O-glycosylation to enhance chemotherapy in pancreatic cancer 114
Exploiting DNA damage response protein O-glycosylation to enhance chemotherapy in pancreatic cancer. 113
Decellularized matrices for tumor cell modeling 111
Targeting Hexosamine Biosynthetic Pathway to Overcome Resistance in Pancreatic Cancer Treatment 109
Inhibition of HBP by targeting PGM3 enzyme as new anticancer therapy 108
Cell-growth and migration inhibition of human mesothelioma cells induced by 3-O-Methylfunicone from Penicillium pinophilum and cisplatin 104
PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response 100
PGM3 inhibition shows cooperative effects with erastin inducing pancreatic cancer cell death via activation of the unfolded protein response 93
3D breast cancer microtissue reveals the role of tumor microenvironment on the transport and efficacy of free-doxorubicin in vitro 92
Hexosamine biosynthetic pathway inhibition cooperates with gemcitabine inducing in vitro and in vivo pancreatic cancer regression by enhancing DNA damage 88
A straightforward method to produce decellularized dermis-based matrices for tumour cell cultures 79
Totale 6.980
Categoria #
all - tutte 25.078
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.078


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023249 0 0 0 0 45 72 47 29 6 18 19 13
2023/2024458 12 7 24 53 47 71 76 23 62 6 16 61
2024/20251.402 63 149 82 78 116 78 122 60 96 191 132 235
2025/20264.334 361 298 450 479 483 281 510 150 384 367 174 397
2026/2027537 219 221 97 0 0 0 0 0 0 0 0 0
Totale 6.980